| Literature DB >> 30263464 |
Subin An1, So Jin Bing1, Jinhee Cho1, Kalahe Hewage Iresha Nadeeka Madushani Herath1,2, Areum Kim1,2, Hyeun Wook Chang3, Youngheun Jee1,2,4.
Abstract
Emodin, one of the major compounds in the herb Reynoutria elliptica, is known to maintain immunosuppressive, anti-allergic, anti-cancer, and anti-inflammatory effects. In this study, we assessed the possibility of using emodin to induce apoptosis in stimulated immune cells in vitro. After treatment with emodin and concanavalin A (Con A), we observed DNA damage-induced apoptosis in splenocytes. Moreover, treatment with emodin and Con A increased the number of apoptotic splenocytes compared with untreated controls. Emodin also diminished the size of CD45R/B220+ cells, CD19+CD69+ cells, and cDC populations. These results indicate that emodin-induced apoptosis was involved in attenuating the immune activity promoted by DNA damage and in decreasing the number of CD45R/B220+ B cells and CD19+CD69+ activating B cells. This demonstration of emodin inducing apoptosis of Con A-stimulated immune cells indicates its potential utility as a therapy for diseases caused by abnormally activated immune cells.Entities:
Keywords: apoptosis; autoimmune disease; concanavalin A; emodin; immune cells
Year: 2016 PMID: 30263464 PMCID: PMC6049233 DOI: 10.1007/s10068-016-0260-y
Source DB: PubMed Journal: Food Sci Biotechnol ISSN: 1226-7708 Impact factor: 2.391